Quick Answer
PROCEPT BioRobotics Corp reported Cash And Cash Equivalents At Carrying Value of $286.50 million for the year ending 2025.
- PROCEPT BioRobotics Corp showed a decrease of -14.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from PROCEPT BioRobotics Corp's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 6 years of available data (2020 to 2025), PROCEPT BioRobotics Corp's Cash And Cash Equivalents At Carrying Value has grown by 186.1%.
- Historical annual values: Fiscal year 2025: $286.50 million | Fiscal year 2024: $333.73 million | Fiscal year 2023: $257.22 million | Fiscal year 2022: $221.86 million | Fiscal year 2021: $304.32 million | Fiscal year 2020: $100.13 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: